Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis

Background: Previous studies have demonstrated that both vitamin C (VC) and vitamin D(3) (VD(3)) have therapeutic potential against metabolic disorders, including obesity, diabetes, and metabolic-associated fatty liver disease (MAFLD). However, it is unclear whether VC supplementation is associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qingling, Zhao, Lili, Mei, Ling, Zhao, Xiaotong, Han, Ping, Liu, Jie, Meng, Chao, Li, Ruifang, Zhong, Rui, Wang, Kai, Li, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113476/
https://www.ncbi.nlm.nih.gov/pubmed/37089915
http://dx.doi.org/10.3389/fphar.2023.1163694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113476/
https://www.ncbi.nlm.nih.gov/pubmed/37089915
http://dx.doi.org/10.3389/fphar.2023.1163694

Ejemplares similares